| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 0450 |
Emergency room services |
76,097 |
65,701 |
$1.22M |
| A0429 |
Ambulance service, basic life support, emergency transport (bls-emergency) |
17,374 |
10,073 |
$807K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
6,926 |
6,169 |
$617K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,525 |
3,108 |
$540K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
9,412 |
7,911 |
$479K |
| 70450 |
Computed tomography, head or brain; without contrast material |
9,701 |
8,843 |
$472K |
| 93458 |
|
522 |
467 |
$411K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
15,131 |
12,963 |
$407K |
| J3490 |
Unclassified drugs |
71,314 |
26,807 |
$402K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
27,461 |
23,614 |
$371K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
10,469 |
9,413 |
$363K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
9,720 |
8,198 |
$345K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
11,926 |
9,553 |
$307K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
5,613 |
4,705 |
$302K |
| Z7502 |
|
7,023 |
6,915 |
$264K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
52,775 |
42,926 |
$237K |
| 71045 |
Radiologic examination, chest; single view |
26,298 |
23,186 |
$236K |
| 83880 |
|
11,878 |
10,340 |
$224K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
10,980 |
8,850 |
$210K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
40,902 |
33,869 |
$198K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
6,743 |
5,803 |
$195K |
| 0270 |
|
91,032 |
37,423 |
$183K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
898 |
810 |
$151K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
25,117 |
17,364 |
$150K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
1,876 |
1,749 |
$138K |
| 84484 |
|
21,885 |
18,319 |
$127K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
3,420 |
3,044 |
$125K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
4,732 |
4,150 |
$124K |
| J1815 |
Injection, insulin, per 5 units |
2,499 |
1,646 |
$116K |
| 99199 |
Unlisted special service, procedure or report |
1,966 |
1,810 |
$111K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
2,456 |
2,227 |
$110K |
| 93971 |
|
1,414 |
1,289 |
$110K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,994 |
3,867 |
$105K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
845 |
781 |
$104K |
| 80076 |
|
24,835 |
21,454 |
$101K |
| 80053 |
Comprehensive metabolic panel |
13,411 |
11,494 |
$91K |
| S3620 |
Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) |
607 |
440 |
$89K |
| A4217 |
Sterile water/saline, 500 ml |
13,739 |
9,162 |
$84K |
| 76830 |
Ultrasound, transvaginal |
1,700 |
1,556 |
$83K |
| 83690 |
|
19,569 |
16,867 |
$82K |
| 93970 |
|
767 |
722 |
$82K |
| L8699 |
Prosthetic implant, not otherwise specified |
369 |
332 |
$81K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
1,811 |
1,651 |
$81K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
1,612 |
1,384 |
$80K |
| 88312 |
|
1,630 |
1,522 |
$78K |
| 76801 |
|
1,640 |
1,408 |
$78K |
| 0272 |
|
10,486 |
9,198 |
$76K |
| Z7610 |
|
4,435 |
2,658 |
$70K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,033 |
5,460 |
$68K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
6,482 |
5,930 |
$63K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
5,095 |
4,064 |
$60K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
719 |
672 |
$60K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
9,037 |
6,453 |
$59K |
| J2785 |
Injection, regadenoson, 0.1 mg |
437 |
408 |
$57K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
1,654 |
1,486 |
$57K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
12,698 |
10,334 |
$57K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
13,840 |
11,438 |
$55K |
| Z9725 |
|
1,230 |
1,218 |
$53K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,150 |
1,107 |
$52K |
| 99291 |
Critical care, evaluation and management of the critically ill patient, first 30-74 minutes |
268 |
259 |
$51K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
1,935 |
1,448 |
$51K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
4,240 |
3,908 |
$50K |
| 80305 |
|
6,072 |
5,409 |
$49K |
| 90715 |
|
1,843 |
1,747 |
$48K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,827 |
1,764 |
$47K |
| 87040 |
|
5,155 |
4,424 |
$45K |
| 71046 |
Radiologic examination, chest; 2 views |
3,375 |
3,142 |
$45K |
| 83605 |
|
6,649 |
5,626 |
$44K |
| 85730 |
|
13,693 |
11,995 |
$42K |
| 81001 |
|
23,308 |
20,434 |
$42K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
9,237 |
8,254 |
$40K |
| 77065 |
Tomosynthesis, mammo |
658 |
599 |
$37K |
| 0360 |
|
9,933 |
4,849 |
$37K |
| Z7500 |
|
1,054 |
454 |
$36K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
1,484 |
1,403 |
$36K |
| 85610 |
|
16,733 |
14,678 |
$35K |
| 81025 |
|
13,328 |
11,917 |
$34K |
| 76641 |
|
646 |
529 |
$34K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
6,279 |
4,936 |
$33K |
| 77066 |
Tomosynthesis, mammo |
308 |
295 |
$33K |
| A9502 |
Technetium tc-99m tetrofosmin, diagnostic, per study dose |
482 |
446 |
$32K |
| 0710 |
|
8,729 |
7,808 |
$31K |
| 73562 |
|
2,051 |
1,890 |
$31K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
7,063 |
6,303 |
$28K |
| 72100 |
|
1,439 |
1,355 |
$28K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
185 |
185 |
$28K |
| 73630 |
|
1,867 |
1,765 |
$28K |
| 70486 |
|
386 |
361 |
$28K |
| 84702 |
|
3,738 |
3,207 |
$27K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
4,256 |
3,556 |
$26K |
| 73030 |
|
1,703 |
1,592 |
$26K |
| 59025 |
Fetal non-stress test |
1,599 |
511 |
$26K |
| 78454 |
|
482 |
442 |
$25K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
64 |
54 |
$24K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,705 |
6,563 |
$24K |
| 73610 |
|
1,517 |
1,424 |
$23K |
| 0160 |
|
1,569 |
823 |
$23K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
6,400 |
5,768 |
$22K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
4,752 |
3,971 |
$22K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
135 |
98 |
$22K |
| 73130 |
|
1,523 |
1,407 |
$21K |
| 81003 |
|
18,459 |
16,582 |
$21K |
| 88313 |
|
1,682 |
1,538 |
$21K |
| 99070 |
|
1,223 |
532 |
$20K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
2,615 |
2,071 |
$19K |
| 82962 |
|
9,822 |
7,606 |
$18K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
3,268 |
2,594 |
$17K |
| 76942 |
|
754 |
676 |
$17K |
| C1769 |
Guide wire |
662 |
595 |
$17K |
| 0250 |
|
17,018 |
5,979 |
$16K |
| 85379 |
|
2,397 |
2,169 |
$16K |
| J1644 |
Injection, heparin sodium, per 1000 units |
4,397 |
2,755 |
$15K |
| 83735 |
|
4,451 |
3,789 |
$15K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
717 |
665 |
$15K |
| 93017 |
|
481 |
443 |
$15K |
| G0378 |
Hospital observation service, per hour |
152 |
106 |
$14K |
| S0020 |
Injection, bupivicaine hydrochloride, 30 ml |
1,335 |
1,164 |
$14K |
| 82550 |
|
3,183 |
2,845 |
$13K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,800 |
2,364 |
$13K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,460 |
1,325 |
$13K |
| 72040 |
|
692 |
669 |
$12K |
| 36415 |
Collection of venous blood by venipuncture |
5,972 |
5,195 |
$12K |
| 87186 |
|
2,488 |
2,239 |
$11K |
| 73110 |
|
709 |
679 |
$11K |
| 76937 |
|
745 |
686 |
$11K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
974 |
854 |
$11K |
| J2060 |
Injection, lorazepam, 2 mg |
2,392 |
1,894 |
$10K |
| 76642 |
|
236 |
216 |
$10K |
| 85027 |
|
2,919 |
2,487 |
$9K |
| 74018 |
|
656 |
620 |
$9K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
2,234 |
1,764 |
$9K |
| 87088 |
|
2,616 |
2,325 |
$9K |
| 96367 |
|
293 |
251 |
$9K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
39 |
36 |
$8K |
| 71250 |
|
84 |
83 |
$8K |
| 94664 |
|
4,158 |
3,718 |
$8K |
| S0164 |
Injection, pantoprazole sodium, 40 mg |
951 |
624 |
$8K |
| 45378 |
Colonoscopy, flexible; diagnostic, including collection of specimen(s) |
309 |
288 |
$7K |
| 87070 |
|
1,699 |
1,568 |
$7K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
420 |
377 |
$7K |
| 36430 |
|
165 |
128 |
$7K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
1,039 |
867 |
$7K |
| 73502 |
|
376 |
351 |
$6K |
| 99292 |
|
43 |
43 |
$6K |
| 72131 |
|
68 |
65 |
$6K |
| 86901 |
|
3,495 |
3,056 |
$6K |
| 83874 |
|
1,126 |
1,061 |
$6K |
| 86900 |
|
3,492 |
3,053 |
$6K |
| 82150 |
|
1,339 |
1,237 |
$6K |
| 86920 |
|
289 |
239 |
$5K |
| 82553 |
|
781 |
692 |
$5K |
| 73590 |
|
387 |
372 |
$5K |
| J7060 |
5% dextrose/water (500 ml = 1 unit) |
1,206 |
1,068 |
$5K |
| 87631 |
|
108 |
100 |
$5K |
| 71010 |
|
324 |
310 |
$5K |
| 87077 |
|
1,252 |
1,123 |
$5K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
333 |
280 |
$5K |
| 85007 |
|
2,722 |
2,329 |
$4K |
| 88304 |
|
788 |
740 |
$4K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
286 |
244 |
$4K |
| J2704 |
Injection, propofol, 10 mg |
1,549 |
1,442 |
$4K |
| 94760 |
|
1,345 |
864 |
$4K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
284 |
201 |
$4K |
| 0762 |
|
1,033 |
740 |
$4K |
| 74022 |
|
247 |
230 |
$4K |
| J7050 |
Infusion, normal saline solution, 250 cc |
1,862 |
1,644 |
$4K |
| 0258 |
|
2,724 |
2,231 |
$4K |
| 80061 |
Lipid panel |
589 |
523 |
$4K |
| 84703 |
|
1,140 |
1,045 |
$3K |
| 86850 |
|
2,148 |
1,844 |
$3K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
262 |
256 |
$3K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,078 |
1,030 |
$3K |
| 87081 |
|
1,238 |
1,079 |
$3K |
| 12001 |
|
242 |
242 |
$3K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
34 |
27 |
$3K |
| 82010 |
|
505 |
466 |
$3K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
338 |
246 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
770 |
751 |
$3K |
| 93975 |
|
16 |
14 |
$3K |
| 94060 |
|
120 |
120 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
515 |
465 |
$3K |
| 87807 |
|
729 |
680 |
$3K |
| 73070 |
|
207 |
200 |
$2K |
| 71101 |
|
147 |
143 |
$2K |
| 82805 |
|
178 |
165 |
$2K |
| 94729 |
|
106 |
106 |
$2K |
| 70496 |
|
17 |
12 |
$2K |
| 47563 |
|
14 |
13 |
$2K |
| 94726 |
|
95 |
95 |
$2K |
| 87147 |
|
645 |
596 |
$2K |
| 93041 |
|
1,807 |
1,705 |
$2K |
| 82040 |
|
875 |
705 |
$2K |
| 96376 |
|
586 |
525 |
$2K |
| 88307 |
|
95 |
75 |
$2K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
249 |
207 |
$1K |
| 10060 |
|
124 |
113 |
$1K |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
2,544 |
2,139 |
$1K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
652 |
609 |
$1K |
| 99000 |
|
369 |
367 |
$1K |
| 86140 |
|
401 |
354 |
$1K |
| 36569 |
|
22 |
21 |
$1K |
| 76770 |
|
28 |
26 |
$1K |
| 97750 |
|
49 |
41 |
$1K |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
192 |
172 |
$1K |
| 47562 |
|
12 |
12 |
$1K |
| 84100 |
|
417 |
354 |
$1K |
| 71020 |
|
36 |
36 |
$1K |
| 82375 |
|
176 |
163 |
$1K |
| 84132 |
|
541 |
502 |
$978.66 |
| 29881 |
|
13 |
13 |
$950.00 |
| 96368 |
|
100 |
67 |
$888.75 |
| 82140 |
|
109 |
105 |
$869.70 |
| 29125 |
|
296 |
285 |
$852.93 |
| 94761 |
|
26 |
14 |
$838.02 |
| 96379 |
|
161 |
157 |
$835.23 |
| 49083 |
|
43 |
25 |
$825.61 |
| J2720 |
Injection, protamine sulfate, per 10 mg |
99 |
88 |
$797.88 |
| 73140 |
|
80 |
80 |
$767.35 |
| 73080 |
|
32 |
31 |
$660.82 |
| J1940 |
Injection, furosemide, up to 20 mg |
183 |
106 |
$652.36 |
| J3411 |
Injection, thiamine hcl, 100 mg |
138 |
108 |
$637.29 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
98 |
52 |
$631.99 |
| C1760 |
Closure device, vascular (implantable/insertable) |
13 |
12 |
$631.16 |
| 84439 |
|
170 |
160 |
$611.56 |
| 0459 |
|
852 |
711 |
$584.72 |
| 83050 |
|
163 |
151 |
$563.82 |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
28 |
25 |
$548.70 |
| 12011 |
|
72 |
72 |
$504.97 |
| 75820 |
|
13 |
12 |
$504.89 |
| 76870 |
|
16 |
14 |
$496.36 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
79 |
54 |
$453.13 |
| 73090 |
|
39 |
38 |
$430.43 |
| 88173 |
|
37 |
36 |
$420.86 |
| 10022 |
|
37 |
37 |
$415.33 |
| 29515 |
|
120 |
114 |
$404.18 |
| C1893 |
Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
38 |
36 |
$401.68 |
| 0760 |
|
1,379 |
638 |
$363.97 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
12 |
12 |
$325.08 |
| J0456 |
Injection, azithromycin, 500 mg |
38 |
15 |
$300.12 |
| 94618 |
|
55 |
55 |
$296.49 |
| 0750 |
|
682 |
578 |
$274.20 |
| 0301 |
|
1,260 |
342 |
$250.43 |
| 74000 |
|
19 |
19 |
$248.20 |
| 51702 |
|
43 |
36 |
$246.32 |
| 97116 |
|
42 |
30 |
$244.05 |
| 82248 |
|
84 |
70 |
$224.68 |
| 76000 |
|
16 |
12 |
$222.41 |
| J3105 |
Injection, terbutaline sulfate, up to 1 mg |
20 |
12 |
$189.77 |
| 36600 |
|
71 |
65 |
$160.55 |
| 0402 |
|
107 |
82 |
$138.77 |
| J9999 |
Not otherwise classified, antineoplastic drugs |
18 |
16 |
$121.99 |
| 73620 |
|
13 |
13 |
$117.93 |
| 85018 |
|
166 |
153 |
$102.75 |
| J2470 |
Injection, pantoprazole sodium, 40 mg |
37 |
29 |
$95.88 |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
19 |
12 |
$79.89 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
262 |
257 |
$77.53 |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
28 |
26 |
$73.05 |
| 0271 |
|
105 |
101 |
$58.47 |
| 87210 |
|
26 |
25 |
$58.24 |
| J1817 |
Insulin for administration through dme (i.e., insulin pump) per 50 units |
13 |
12 |
$50.43 |
| 81002 |
|
85 |
81 |
$44.33 |
| J3480 |
Injection, potassium chloride, per 2 meq |
108 |
81 |
$28.92 |
| 86308 |
|
13 |
13 |
$28.72 |
| 84550 |
|
14 |
12 |
$25.68 |
| C9399 |
Unclassified drugs or biologicals |
234 |
222 |
$25.26 |
| 0636 |
|
516 |
354 |
$17.66 |
| 0306 |
|
492 |
324 |
$15.70 |
| 0305 |
|
657 |
314 |
$12.28 |
| J1630 |
Injection, haloperidol, up to 5 mg |
13 |
13 |
$11.47 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
50 |
50 |
$9.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
41 |
41 |
$8.68 |
| 85651 |
|
13 |
12 |
$7.85 |
| C9290 |
Injection, bupivacaine liposome, 1 mg |
155 |
155 |
$5.96 |
| 0307 |
|
153 |
139 |
$5.02 |
| 29130 |
|
14 |
14 |
$1.99 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
174 |
67 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
15 |
15 |
$0.00 |
| 0361 |
|
96 |
93 |
$0.00 |
| G9656 |
Patient transferred directly from anesthetizing location to pacu or other non-icu location |
285 |
285 |
$0.00 |
| L1830 |
Knee orthosis, immobilizer, canvas longitudinal, prefabricated, off-the-shelf |
13 |
13 |
$0.00 |
| 99215 |
Prolong outpt/office vis |
286 |
286 |
$0.00 |
| 0302 |
|
53 |
17 |
$0.00 |
| 0351 |
|
68 |
59 |
$0.00 |
| 0320 |
|
301 |
248 |
$0.00 |
| 0300 |
|
71 |
64 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
17 |
17 |
$0.00 |
| 0370 |
|
668 |
643 |
$0.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
15 |
13 |
$0.00 |
| 0720 |
|
1,067 |
489 |
$0.00 |
| 0350 |
|
86 |
75 |
$0.00 |
| 0310 |
|
75 |
38 |
$0.00 |